Skip to content
Review

Immunotherapeutic strategies for castration-resistant prostate cancer: A systematic review of mechanisms, clinical advances and emerging approaches

Jul 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 74 references
Medicine

TL;DR

The findings demonstrate the significant potential of immunotherapy in treating CRPC, but treatment regimens require further optimization and validation of long-term survival benefits through Phase III clinical trials.

View source

Similar papers

Review

IMMUNOTHERAPY STRATEGIES FOR

This review aims to discuss current and emerging treatment approaches based on modulation of the immune response, with particular emphasis on immune checkpoint inhibitors, targeted therapies, and mRNA vaccines.

Artur Marcysiak, Patrycja Mularczyk, Nina Polek et al. · 1 citation
Review Open access Aug 2026

Narrative review of research progress and future development of bispecific antibodies in lung cancer: opportunities and challenges

The research on BsAbs in lung cancer therapy is characterized, with a focus on their mechanisms of action, clinical development, current challenges, and future directions, to represent a promising therapeutic strategy for lung cancer.

Yun-Fei Dai, Jing Fei · 0 citations
Review Open access Aug 2026

Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer

Key approaches targeting DNA repair deficiency, immune regulation, oncogenic signaling pathways, and antigen-directed therapies are highlighted, and their clinical development and application are discussed.

Hui-Fang Cheng, Yanmei Chen, Pei-Yan Liu et al. · 0 citations
Review Open access Aug 2026

Emerging Therapeutic Strategies in Small-Cell Lung Cancer: From Adaptive Resistance to Precision Therapy

The evolving biological basis of therapeutic resistance is examined and how emerging treatment strategies may be integrated into biologically informed clinical development is discussed to improve patient selection, guide therapeutic sequencing, and increase the durability of treatment benefit in extensive-stage SCLC.

Jun Kim, Seounghun Kang · 0 citations
Review Aug 2026

Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions.

Immunotherapy has reshaped the treatment landscape of colorectal cancer (CRC), with the clearest and most durable benefit established in mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) disease. However, framing CRC immunotherapy simply as "MSI-H responsive versus microsatellite stable (MSS) res...

En-Geng Chen, Gao-Yang Cao, Zhang-Fa Song · 0 citations
Review Open access Sep 2026

NEW IMMUNOTHERAPY STRATEGIES FOR MELANOMA: CHECKPOINT INHIBITORS, COMBINATION THERAPIES AND mRNA VACCINES

Current and emerging treatment approaches based on modulation of the immune response, with particular emphasis on immune checkpoint inhibitors, targeted therapies, and mRNA vaccines are discussed.

Artur Marcysiak, Patrycja Mularczyk, Nina Polek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.